Michele Kearney's Nuclear Wire - Major Energy and Environmental News and Commentary affecting the Nuclear Industry. Nuclear Activities
Wednesday, February 3, 2021
Intranasal influenza vaccine spurs strong immune response in Phase 1 study | National Institutes of Health (NIH)
Intranasal influenza vaccine spurs strong immune response in Phase 1 study | National Institutes of Health (NIH): The vaccine platform could be highly adaptable for use against other viruses.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment